Author(s):
S. Janet Beula, T. Ramamohan Reddy, M. Viswaja, Y. Ramulu
Email(s):
pharmjanet123@gmail.com
DOI:
10.52711/2231-5675.2022.00021 
Address:
S. Janet Beula1*, T. Ramamohan Reddy2, M. Viswaja3, Y. Ramulu4
1Teegala Ram Reddy College of Pharmacy, Meerpet, RR District, Telangana, India.
2CMR College of Pharmacy, Medchal, RR District, Telangana, India.
3Vijaya College of Pharmacy, Munuganoor, RR District, Telangana, India.
4Sree Dattha Institute of Pharmacy, Ibrahimpatanam, RR District, Telangana, India.
*Corresponding Author
Published In:
Volume - 12,
Issue - 2,
Year - 2022
ABSTRACT:
The present work describes a reverse phase high performance liquid chromatographic method (RP-HPLC) for the simultaneous estimation of Flupentixol and Melitracen in bulk and in tablet dosage form. Chromatographic separation was performed on Hypersil (C18) (250mm x 4.6mm, 5µm) Column, with a mobile phase comprising of a mixture of methanol and Acetonitrile in the ratio of 34:66v/v. The flow rate was 1.0ml/min with detection at 257nm. Retention times of Flupentixol and Melitracen were found to be 1.791min and 3.465min respectively. As per International Conference on Harmonization (ICH) guidelines the method was validated for linearity, accuracy, precision, limit of quantitation, limit of detection, and robustness. Linearity of Flupentixol was found to be in the range of 60-140µg/mL. and that for Melitracen was found to be 30-70µg/mL. The Precision (Repeatability, Intra-day and Inter-day) of the Flupentixol and Melitracen was found to be within the limits. The correlation coefficients were 0.999 and 0.999 for Flupentixol and Melitracen respectively. The mean recoveries obtained for Flupentixol and Melitracen were 100.28% and 99.79%. This demonstrates that the developed method is simple, precise, accurate, reproducible and rapid for simultaneous estimation of these drugs in bulk and in tablet dosage forms.
Cite this article:
S. Janet Beula, T. Ramamohan Reddy, M. Viswaja, Y. Ramulu. Stability Indicating RP-HPLC Method Development and Validation for The Simultaneous Estimation of Flupentixol and Melitracen in API from and Marketed Tablet Dosage form. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):115-0. doi: 10.52711/2231-5675.2022.00021
Cite(Electronic):
S. Janet Beula, T. Ramamohan Reddy, M. Viswaja, Y. Ramulu. Stability Indicating RP-HPLC Method Development and Validation for The Simultaneous Estimation of Flupentixol and Melitracen in API from and Marketed Tablet Dosage form. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):115-0. doi: 10.52711/2231-5675.2022.00021 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2022-12-2-9
REFERENCES:
1. Snyder LR practical HPLC method development, 2nd edition. John Wiley and sons, New York, 1997; PP 180-182.
2. Skoog D A, West D M, Holler FJ: Introduction of analytical chemistry. Sounder college of publishing, Harcourt Brace College Publishers. 1994; PP 1-5.
3. Sharma B K, Instrumental Method of Chemical Analysis Meerut. 1999; PP 175-203.
4. Breaux J and Jones K: Understanding and implementing efficient analytical method development and validation. Journal of Pharmaceutical Technology, 2003; 5, PP 110-114.
5. Willard, H. y. Merritt L.L, Dean J.A and Settle F.A Instrumental methods of analysis. 7th edition CBS Publisher and Distributors, New Delhi, 1991; PP 436-439.
6. ICH Q2A. Validation of analytical methods, definitions and terminology. ICH Harmonized tripartite guideline, 1999.
7. Skoog D.A., Holler F.J., Nieman T.A. Principles of Instrumental Analysis. 5th edition 2005; PP 733-738.
8. Beckett HA and Stenlake BJ. Practical Pharmaceutical chemistry. CBS Publishers. New Delhi; 4th Edition (2003), PP 168-9.
9. British Pharmacopoeia: Convention Inc., Rockville, 2008; Vol.I: 965-966.
10. Sharma BK: Instrumental Methods of Chemical Analysis. Goel Publishers; Meerut, 3rd edition 2005; PP 861-76.
11. Gennaro, A.R., Remington. The Science and Practice of Pharmacy, 28th edition, Luppincott, Williams and Wilkins, Baltimore, Maryland, USA, 2000; PP 534 - 549.
12. Ghulam A. Shabir: HPLC Method Development and Validation for Pharmaceutical Analysis. 2004; PP 25-27.
13. International Conference on Harmonization: ICH Q 2 (R1) Validation of Analytical Procedure, Text and Methodology 1995.
14. L. R. Snyder, J.J. Kirkland, and J. L. Glajch, Practical HPLC Method Development, John Wiley and Sons, New York, 1997.
15. S. Ahuja and H. T. Rasmussen (ed), HPLC Method Development for Pharmaceuticals, Academic Press, 2007.
16. S. Ahuja and M.W. Dong (ed), Handbook of Pharmaceutical Analysis by HPLC, Elsevier/Academic Press, 2005.
17. Y. V. Kazakevich and R. Lo Brutto (ed.), HPLC for Pharmaceutical Scientists, Wiley, 2007.
18. U. D. Neue, HPLC Columns: Theory, Technology, and Practice, Wiley-VCH, New York, 1997.
19. M. C. McMaster, HPLC, a practical user's guide, Wiley, 2007.
20. Michael, D.R., Stephen, P.H.A., and David, A.K., Pharmacology, Pharmaceutical Press, London, Chicago 2009.